Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Rituximab/vinblastine

Drug ineffective and rebound effect in form of progression of Rosai Dorfman disease: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Fard-Esfahani A, et al. Potential role of 18F-FDG PET/CT in a case of progressive rosai dorfman disease. Asia Oceania Journal of Nuclear Medicine and Biology 9: 62-66, No. 1, 2021. Available from: URL: https://aojnmb.mums.ac.ir Fard-Esfahani A, et al. Potential role of 18F-FDG PET/CT in a case of progressive rosai dorfman disease. Asia Oceania Journal of Nuclear Medicine and Biology 9: 62-66, No. 1, 2021. Available from: URL: https://​aojnmb.​mums.​ac.​ir
Metadaten
Titel
Rituximab/vinblastine
Drug ineffective and rebound effect in form of progression of Rosai Dorfman disease: case report
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41622-5

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Fostamatinib

Case report

Clopidogrel

Case report

Thiotepa

Case report

Bisoprolol